Videoscope-Assisted Surgery for Gum Disease
Trial Summary
What is the purpose of this trial?
Clinical and preclinical studies confirm that regeneration of supporting tissues of teeth lost due to periodontal disease can be achieved using the principles of minimally invasive surgery (MIS). Although this therapeutic approach is well established in clinical settings and can rescue teeth with poor or questionable prognosis, MIS approaches often suffer from lack of predictability due to poor intraoral visibility of the bony lesion and inability to confirm thorough removal of etiological factors (plaque/calculus) on tooth surfaces. We seek to investigate whether improved visualization of the surgical field using an FDA approved videoscope (V) improves clinical outcomes. For this pilot study, N=50 (to attain 10/group) age, sex matched, systemically healthy subjects diagnosed with Stage III, Grade B periodontitis, formerly known as severe chronic periodontitis, will be randomly assigned to either the VMIS (Test), MIS (Control 1) or Guided Tissue Regeneration (GTR, Control 2) group. All periodontal therapy will be performed following the Standard of Care for periodontal regeneration to determine if utilization of the videoscope improves clinical and radiographic outcomes. We will examine bone fill using conventional digital periapical radiographs (PAR) and Cone Beam Computed Tomography (CBCT) imaging at 6 and 12 months compared to baseline and collect gingival crevicular fluid (GCF) to compare expression of growth factors and cytokines/chemokines during the healing period. This is a single center treatment study where subjects will be recruited from individuals seeking periodontal treatment at the Graduate Periodontics Clinic, UIC College of Dentistry (COD). Participation of all subjects will end after 12 months and will comprise 7 total visits.
Will I have to stop taking my current medications?
The trial requires that participants not take medications known to affect immunity or periodontal tissues, such as steroids, antibiotics, or phenytoin, in the previous 6 months. Participants also cannot be on chronic anti-platelet or anti-coagulant therapy.
What data supports the effectiveness of the treatment Videoscope-Assisted Surgery for Gum Disease?
Research shows that guided tissue regeneration (GTR), a key component of this treatment, is effective in regenerating periodontal tissues lost to gum disease. Many studies have documented its success in reconstructive periodontal surgery, making it a widely accepted procedure in dental practices.12345
Is videoscope-assisted surgery for gum disease safe?
How is videoscope-assisted surgery for gum disease different from other treatments?
Videoscope-assisted surgery for gum disease is unique because it combines guided tissue regeneration (GTR), which aims to regrow lost bone and tissue, with minimally invasive techniques that use a videoscope (a small camera) to enhance precision and reduce recovery time compared to traditional surgery.24589
Research Team
Salvador Nares, DDS, PhD
Principal Investigator
University of Illinois at Chicago
Eligibility Criteria
This trial is for systemically healthy adults aged 18-70 with severe chronic periodontitis, evidenced by specific dental measurements and radiographs. Candidates must have good oral hygiene (plaque scores ≤20%) and be English-speaking to follow study procedures. Excluded are pregnant women, smokers, those on certain medications or with systemic disorders affecting healing, and individuals with non-isolated gum disease or certain dental restorations.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo periodontal therapy using either VMIS, MIS, or GTR techniques to improve clinical and radiographic outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment, with bone fill examined using radiographs and CBCT imaging
Treatment Details
Interventions
- Guided tissue regeneration surgery
- Periodontal regeneration minimally invasive surgery
- Videoscope-assisted periodontal regeneration minimally invasive surgery
Guided tissue regeneration surgery is already approved in United States, European Union for the following indications:
- Periodontal disease
- Bone loss around teeth
- Periodontal disease
- Bone loss around teeth
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor